Skip to main content
OpenTrials

Clinical trial condition

Adenocarcinoma

Explore clinical trials studying Adenocarcinoma. Study availability and eligibility vary by location and protocol.

445 public trials 103 recruiting studies
Refine in advanced search Browse all conditions

Adenocarcinoma trial results

Completed

A Study Comparing CO-1.01 With Gemcitabine as First Line Therapy in Patients With Metastatic Pancreatic Adenocarcinoma (LEAP)

NCT01124786

Conditions
Adenocarcinoma, Carcinoma, Metastatic Pancreatic Adenocarcinoma, +7 more
Locations
  • Arizona Center for Hematology Oncology Glendale, Arizona, United States
  • Wilshire Oncology Medical Group, Inc. Corona, California, United States
  • White Memorial Medical Center Los Angeles, California, United States
  • Cancer Care Institute Los Angeles, California, United States
View all 95 locations
View Trial Details
Completed

Gemcitabine and Sorafenib in Advanced Biliary Tract Cancer (GEMSO)

NCT00661830

Conditions
Adenocarcinoma, Carcinoma, Neoplasm Metastasis, +6 more
Locations
  • Klinikum der Johannes Gutenberg-Universität Mainz, I. Med. Klinik Mainz, Rhineland-Palatinate, Germany
  • Universitätsklinikum Jena, Klinik für Innere Medizin, Innere Medizin II D-07740 Jena, Germany
  • Universitätsklinikum Hamburg-Eppendorf, I. Med. Klinik, Zentrum für Innere Medizin, Martinistr. 3 D-20248 Hamburg, Germany
  • Klinikum Fulda gAG, Tumorklinik, Pacelliallee 4 D-36043 Fulda, Germany
View Trial Details
Completed

A Study Of AG-013736 (Axitinib) Or Bevacizumab (Avastin) In Combination With Paclitaxel And Carboplatin In Patients With Advanced Lung Cancer.

NCT00600821

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +12 more
Locations
  • Pfizer Investigational Site Baton Rouge, Louisiana, United States
  • Pfizer Investigational Site Pittsfield, Massachusetts, United States
  • Pfizer Investigational Site Columbus, Mississippi, United States
  • Pfizer Investigational Site Corinth, Mississippi, United States
View all 44 locations
View Trial Details
Completed

Study Evaluating Biomarkers In Relapsed/Refractory Pediatric Solid Tumors

NCT00106353

Conditions
Adenocarcinoma, Carcinoma, Neoplasms, +2 more
Locations
  • Pfizer Investigational Site Birmingham, Alabama, United States
  • Pfizer Investigational Site San Francisco, California, United States
  • Pfizer Investigational Site Chicago, Illinois, United States
  • Pfizer Investigational Site Indianapolis, Indiana, United States
View all 30 locations
View Trial Details

Related conditions